• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Sunitinib Treatment Exacerbates intratumoral Heterogeneity in Metastatic Renal Cancer 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Experimental Cancer Medicine
    • Sunitinib Treatment Exacerbates intratumoral Heterogeneity in Metastatic Renal Cancer
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Experimental Cancer Medicine
    • Sunitinib Treatment Exacerbates intratumoral Heterogeneity in Metastatic Renal Cancer
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Sunitinib Treatment Exacerbates intratumoral Heterogeneity in Metastatic Renal Cancer

    Volume
    21
    Pagination
    4212 - 4223
    DOI
    10.1158/1078-0432.CCR-15-0207
    Journal
    CLINICAL CANCER RESEARCH
    Issue
    18
    ISSN
    1078-0432
    Metadata
    Show full item record
    Authors
    Stewart, GD; O'Mahony, FC; Laird, A; Eory, L; Lubbock, ALR; Mackay, A; Nanda, J; O'Donnell, M; Mullen, P; McNeill, SA
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/11015
    Collections
    • Centre for Experimental Cancer Medicine [123]
    Licence information
    • “The final publication is available at http://clincancerres.aacrjournals.org/content/21/18/4212.long”
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.